These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2142024)

  • 1. Inhibitors of ANF metabolism. Potential therapeutic agents in cardiovascular disease.
    Granger JP
    Circulation; 1990 Jul; 82(1):313-5. PubMed ID: 2142024
    [No Abstract]   [Full Text] [Related]  

  • 2. Enkephalinase (EC 3.4.24.11) inhibitors: protection of endogenous ANF against inactivation and potential therapeutic applications.
    Schwartz JC; Gros C; Lecomte JM; Bralet J
    Life Sci; 1990; 47(15):1279-97. PubMed ID: 2146457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan.
    Gros C; Souque A; Schwartz JC; Duchier J; Cournot A; Baumer P; Lecomte JM
    Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7580-4. PubMed ID: 2529543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of neutral endopeptidase in dogs with evolving congestive heart failure.
    Margulies KB; Barclay PL; Burnett JC
    Circulation; 1995 Apr; 91(7):2036-42. PubMed ID: 7895362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UK-69,578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic.
    Danilewicz JC; Barclay PL; Barnish IT; Brown D; Campbell SF; James K; Samuels GM; Terrett NK; Wythes MJ
    Biochem Biophys Res Commun; 1989 Oct; 164(1):58-65. PubMed ID: 2529858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal tubular responsiveness to atrial natriuretic peptide in sodium-retaining chronic caval dogs. A possible role for kinins and luminal actions of the peptide.
    Legault L; Cernacek P; Levy M; Maher E; Farber D
    J Clin Invest; 1992 Oct; 90(4):1425-35. PubMed ID: 1328299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure.
    Münzel T; Kurz S; Holtz J; Busse R; Steinhauer H; Just H; Drexler H
    Circulation; 1992 Oct; 86(4):1089-98. PubMed ID: 1394917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of UK 69 578: a novel atriopeptidase inhibitor.
    Northridge DB; Jardine AG; Alabaster CT; Barclay PL; Connell JM; Dargie HJ; Dilly SG; Findlay IN; Lever AF; Samuels GM
    Lancet; 1989 Sep; 2(8663):591-3. PubMed ID: 2570286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the metabolism of atrial natriuretic factor causes diuresis and natriuresis in chronic heart failure.
    Northridge DB; Jardine AG; Findlay IN; Archibald M; Dilly SG; Dargie HJ
    Am J Hypertens; 1990 Sep; 3(9):682-7. PubMed ID: 2145874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and renal effects of atrial natriuretic factor.
    Luft FC; Lang RE; Ruskoaho H; Sterzel RB; Unger T; Ganten D
    Adv Nephrol Necker Hosp; 1987; 16():37-51. PubMed ID: 2949545
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure.
    Cavero PG; Margulies KB; Winaver J; Seymour AA; Delaney NG; Burnett JC
    Circulation; 1990 Jul; 82(1):196-201. PubMed ID: 2142023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The atriopeptidase inhibitor UK 69,578 increases atrial natriuretic factor and causes a natriuresis in normal humans.
    Jardine AG; Connell JM; Northridge D; Dilly SG; Cussans NJ; Davidson G; Doyle J; Leckie BL; Lever AF
    Am J Hypertens; 1990 Sep; 3(9):661-7. PubMed ID: 2145871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natriuretic peptide family: turning hormones into drugs.
    Wilkins MR; Nunez DJ; Wharton J
    J Endocrinol; 1993 Jun; 137(3):347-59. PubMed ID: 8371073
    [No Abstract]   [Full Text] [Related]  

  • 15. Endopeptidase-24.11 and its inhibitors: potential therapeutic agents for edematous disorders and hypertension.
    Wilkins MR; Unwin RJ; Kenny AJ
    Kidney Int; 1993 Feb; 43(2):273-85. PubMed ID: 8441223
    [No Abstract]   [Full Text] [Related]  

  • 16. Degradation of atrial natriuretic peptides by an enzyme in rat kidney resembling neutral endopeptidase 24.11.
    Bertrand P; Doble A
    Biochem Pharmacol; 1988 Oct; 37(20):3817-21. PubMed ID: 2973321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency].
    Varin J; Duboc D; Weber S; Fouchard J; Schwartz JC; Muffat-Joly M; Guérin F
    Arch Mal Coeur Vaiss; 1991 Oct; 84(10):1465-71. PubMed ID: 1662033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal natriuretic effects of atrial natriuretic peptide in dogs with alloxan-induced acute pulmonary edema.
    Levy M; Cernacek P
    Clin Invest Med; 1996 Dec; 19(6):435-43. PubMed ID: 8959353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vasopeptidase inhibitors. Clinical implications of a new class of drugs].
    Quaschning T; Corti R; Ruschitzka FT; Noll G; Lüscher TF
    Dtsch Med Wochenschr; 2000 Apr; 125(16):499-503. PubMed ID: 10819011
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal hemodynamic and natriuretic effects of atrial natriuretic factor.
    Maack T; Atlas SA; Camargo MJ; Cogan MG
    Fed Proc; 1986 Jun; 45(7):2128-32. PubMed ID: 3011521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.